Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹384 Cr
down ₹25.2 Cr vs Jul 2025
- Stocks held
- 16
- up 1 vs Jul 2025
- Top 10 weight
- 70.0%
- of the portfolio in its ten largest
- Cash & debt
- 1.4%
- cash, money market and debt
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In August 2025 it disclosed 16 stocks worth ₹384 Cr, down ₹25.2 Cr from Jul 2025. Its largest positions were Aster DM Healthcare Limited (10.1%), RPG Life Sciences Limited (9.1%), Anthem Biosciences Limited (6.8%); the ten largest together made up 70.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 65.8% of its equity. Cash and debt stood at 1.4%. Compared with Jul 2025 the fund entered 2 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
3%
Holds more stocks than 3% of peers
Cash
19%
Holds more cash than 19% of peers
What these mean: concentration · cash
Holdings in August 2025
Download CSVEvery line the fund disclosed, with the change against Jul 2025. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Aster DM Healthcare Limited | 10.05% | up 0.04 pts | ₹38.6 Cr | down ₹2.4 Cr | Trimmed |
| RPG Life Sciences Limited | 9.10% | up 0.26 pts | ₹34.9 Cr | down ₹1.2 Cr | Trimmed |
| Anthem Biosciences Limited | 6.82% | up 0.88 pts | ₹26.2 Cr | up ₹1.9 Cr | Added |
| Zydus Wellness Limited | 6.75% | up 0.38 pts | ₹25.9 Cr | down ₹13 L | Trimmed |
| Lupin Limited 30/09/2025 Derivative | 6.52% | up 6.52 pts | ₹25 Cr | up ₹25 Cr | New |
| Sequent Scientific Limited | 6.51% | up 0.31 pts | ₹25 Cr | down ₹38 L | Trimmed |
| Pfizer Limited | 6.44% | up 0.35 pts | ₹24.7 Cr | down ₹18 L | Trimmed |
| Glenmark Life Sciences Limited | 6.06% | down 0.15 pts | ₹23.3 Cr | down ₹2.1 Cr | Trimmed |
| HDFC Life Insurance Company Limited | 5.98% | up 0.49 pts | ₹23 Cr | up ₹49 L | Added |
| Aurobindo Pharma Limited | 5.82% | down 0.24 pts | ₹22.3 Cr | down ₹2.4 Cr | Trimmed |
| SMS Pharmaceuticals Limited | 5.14% | up 0.37 pts | ₹19.7 Cr | up ₹21 L | Added |
| Max Healthcare Institute Limited | 4.25% | down 0.06 pts | ₹16.3 Cr | down ₹1.3 Cr | Trimmed |
| Concord Biotech Limited | 3.66% | up 3.66 pts | ₹14 Cr | up ₹14 Cr | New |
| Sun Pharmaceutical Industries Limited | 3.21% | down 0.01 pts | ₹12.3 Cr | down ₹87 L | Trimmed |
| Sun Pharmaceutical Industries Limited 30/09/2025 Derivative | 3.03% | up 3.03 pts | ₹11.6 Cr | up ₹11.6 Cr | New |
| Lupin Limited | 2.81% | up 0.13 pts | ₹10.8 Cr | down ₹19 L | Trimmed |
| Laxmi Dental Limited | 2.55% | down 0.44 pts | ₹9.8 Cr | down ₹2.4 Cr | Trimmed |
| Aurobindo Pharma Limited 30/09/2025 Derivative | 2.52% | up 2.52 pts | ₹9.7 Cr | up ₹9.7 Cr | New |
| Gland Pharma Limited | 1.37% | up 1.37 pts | ₹5.3 Cr | up ₹5.3 Cr | New |
| 91 Days Treasury Bill 18-Sep-2025 Debt | 1.04% | up 0.07 pts | ₹4 Cr | up ₹2 L | Held |
| 91 Days Treasury Bill 25-Sep-2025 Debt | 0.78% | up 0.05 pts | ₹3 Cr | up ₹1 L | Held |
| 91 Days Treasury Bill 20-Nov-2025 Debt | 0.77% | up 0.77 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 28-Nov-2025 Debt | 0.77% | up 0.77 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 11-Sep-2025 Debt | 0.52% | up 0.03 pts | ₹2 Cr | up ₹1 L | Held |
| 182 Days Treasury Bill 04-Sep-2025 Debt | 0.26% | up 0.02 pts | ₹100 L | up ₹0 L | Held |
| 91 Days Treasury Bill 04-Sep-2025 Debt | 0.26% | up 0.02 pts | ₹100 L | up ₹0 L | Held |
| Cash, TREPS & receivables | −2.98% | up 0.95 pts | −₹11.4 Cr | up ₹4.7 Cr | Added |
What changed, Jul 2025 to Aug 2025
New New positions (2)
- Concord Biotech Limited3.7% · ₹14 Cr
- Gland Pharma Limited1.4% · ₹5.3 Cr
Exited Exited (1)
- HFCL Limitedwas 4.4% · ₹18.1 Cr
Added Biggest additions
- Anthem Biosciences Limitedup ₹1.9 Cr (+0.88% pts)
- HDFC Life Insurance Company Limitedup ₹49 L (+0.49% pts)
- SMS Pharmaceuticals Limited ₹21 L (+0.37% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2025, the weight rose most in Pharmaceuticals & Biotechnology (+6.0 pts) and Insurance (+0.3 pts), and fell most in Telecom - Services (−5.3 pts) and Healthcare Equipment & Supplies (−0.6 pts).
- Pharmaceuticals & Biotechnology59.8% → 65.8%+6.0 pts
- Insurance6.6% → 6.9%+0.3 pts
- Food Products7.6% → 7.8%+0.2 pts
- Telecom - Services5.3% → 0.0%exited−5.3 pts
- Healthcare Equipment & Supplies3.6% → 3.0%−0.6 pts
- Healthcare Services17.1% → 16.5%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2024 | Feb 2025 | May 2025 | Jul 2025 | Aug 2025 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.3% | 70.4% | 64.9% | 59.8% | 65.8% |
| Healthcare Services | 9.6% | 11.1% | 14.4% | 17.1% | 16.5% |
| Food Products | 7.7% | 5.9% | 7.2% | 7.6% | 7.8% |
| Insurance | — | — | 6.9% | 6.6% | 6.9% |
| Healthcare Equipment & Supplies | — | — | 0.6% | 3.6% | 3.0% |
Allocation in Aug 2025change vs Jul 2025
- Pharmaceuticals & Biotechnology (11)65.8%▲ 6.0 pts
- Healthcare Services (2)16.5%▼ 0.6 pts
- Food Products (1)7.8%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2025
1.4%
▲ 0.7 pts vs Jul 2025
- Cash alone
- −3.0%
- cash and net receivables
- A year earlier
- 7.0%
- Aug 2024 · now ▼ 5.6 pts
- Last 12 months
- 0.2% – 3.2%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.